Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

PAPCC COALITION — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

PAPCC COALITION

via LEAVITT PARTNERS, LLC

1st Quarter (Jan 1 - Mar 31) · 2018Posted Apr 13, 2018Filing document ↗LDA record ↗

Income$60Kfee reported

Client

Name: PAPCC COALITION
Description: pharmaceutical and patient safety issues
Location: District of Columbia · United States of America

Registrant

Firm: LEAVITT PARTNERS, LLC
Description: Consulting.
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
S.109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
LobbyistsVINCE VENTIMIGLIA jr · DAVID LEE · ROBERT HORNE
Covered position (VINCE VENTIMIGLIA jr): Assistant Secretary for Legislation - HHS; Legislative Assistant - Senate; Policy Director - Senate
Covered position (DAVID LEE): Staff Assistant - Senate; Legislative Correspondent - Senate
Covered position (ROBERT HORNE): Professional Staff Energy and Commerce Committee - House; Senior Legislative Assistant - House; Legislative Assistant - House
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.